Less than 1% of ARPKD patients have pathogenic sequence variants either in DZIP1L or CYS1 genes (Lu et al., 2017; Yang et al., 2021), and the molecular cause of ARPKD in remaining patients remains to be determined (Bergmann, 2017). This evidence concerns the gene DZIP1L and autosomal recessive polycystic kidney disease.